<DOC>
	<DOCNO>NCT00005830</DOCNO>
	<brief_summary>Phase I trial study effectiveness combination chemotherapy plus radiation therapy treat woman stage III stage IV endometrial cancer . Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Radiation therapy use high-energy x-rays damage tumor cell . Combining chemotherapy radiation therapy may kill tumor cell .</brief_summary>
	<brief_title>Combination Chemotherapy Plus Radiation Therapy Treating Patients With Stage III Stage IV Endometrial Cancer</brief_title>
	<detailed_description>OBJECTIVES : I . Determine feasibility doxorubicin cisplatin follow whole abdominal radiotherapy patient stage III IV endometrial cancer . II . Determine acute chronic toxic effect , particular , severe life-threatening gastrointestinal , hepatic , hematologic toxic effect , regimen patient . OUTLINE : This multicenter study . Patients receive doxorubicin IV cisplatin IV day 1 . Treatment repeat every 3 week 3 course . Patients undergo whole abdominal radiotherapy 5 day week 4-6 week . Patients follow every 3 month 2 year , every 6 month 3 year , annually thereafter . PROJECTED ACCRUAL : A total 21-53 patient accrue study within 3.5 year .</detailed_description>
	<mesh_term>Adenocarcinoma</mesh_term>
	<mesh_term>Uterine Neoplasms</mesh_term>
	<mesh_term>Cystadenocarcinoma , Serous</mesh_term>
	<mesh_term>Adenocarcinoma , Clear Cell</mesh_term>
	<mesh_term>Liposomal doxorubicin</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Doxorubicin</mesh_term>
	<criteria>Histologically confirm endometrial cancer include 1 follow subtypes : Clear cell carcinoma Serous papillary carcinoma Endometrioid adenocarcinoma Stage III IV disease Positive adnexa Metastases serosa , bowel mucosa , abdomen Positive pelvic paraaortic node Positive pelvic washing vaginal involvement within radiation port Tumor must surgically reduce 2 cm less within 8 week study entry Must hysterectomy bilateral salpingo oophorectomy No recurrent disease No distant metastasis outside abdominopelvic area , include : Parenchymal liver metastasis Lung metastasis Positive inguinal lymph node Positive supraclavicular node Pleural effusion malignant cytology Performance status GOG 02 Absolute neutrophil count least 1,500/mm^3 Platelet count least 100,000/mm^3 Bilirubin great 1.5 time upper limit normal ( ULN ) SGOT alkaline phosphatase great 3 time ULN Creatinine great ULN Cardiac ejection fraction great 50 % No prior concurrent malignancy within past 5 year except nonmelanoma skin cancer No prior chemotherapy No prior pelvic abdominal radiotherapy No prior radiotherapy prior malignancy</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
</DOC>